2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Carcinoma, Basal Cell
6
Lung Neoplasms
4
Breast Neoplasms
3
Skin Neoplasms
2
Precancerous Conditions
2
Pancreatic Neoplasms
2
Neoplasms
2
Keratosis, Actinic
2
Urologic Neoplasms
1
Urinary Bladder Neoplasms
1
Telangiectasis
1
Stomatitis
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Rosacea
1
Recurrent respiratory papillomatosis
1
Prostatic Neoplasms
1
Port-Wine Stain
1
Pancreatic Intraductal Neoplasms
1
Non-melanoma Skin Cancer
1
Nevus, Pigmented
1
Neoplasm Metastasis
1
Nasopharyngeal Neoplasms
1
Mouth Neoplasms
1
Mouth Diseases
1
Mixed Tumor, Malignant
1
Mesothelioma, Malignant
1
Melanoma
1
Lichen Planus, Oral
1
Leukoplakia, Oral
1
Interventions
Imiquimod
4
tirbanibulin
3
Cryotherapy
2
methyl 5-aminolevulinate
1
Tomography, Optical Coherence
1
Sugars
1
Ointments
1
Lasers, Gas
1
Fluorouracil
1
BF-200 ALA
1
3-ingenyl angelate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Keratosis
×
Tomography, Optical Coherence
×
Clear all
NCT02851693
2019-04-04
OCTSKIN
Centre Hospitalier Universitaire de Saint Etienne
Phase NA
Withdrawn